1. Home
  2. FSK vs BLLN Comparison

FSK vs BLLN Comparison

Compare FSK & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FS KKR Capital Corp.

FSK

FS KKR Capital Corp.

HOLD

Current Price

$14.49

Market Cap

4.2B

Sector

Finance

ML Signal

HOLD

BLLN

BillionToOne Inc.

N/A

Current Price

$99.80

Market Cap

3.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FSK
BLLN
Founded
2007
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
3.9B
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
FSK
BLLN
Price
$14.49
$99.80
Analyst Decision
Hold
Buy
Analyst Count
6
6
Target Price
$17.33
$137.83
AVG Volume (30 Days)
2.8M
210.6K
Earning Date
02-25-2026
12-09-2025
Dividend Yield
19.22%
N/A
EPS Growth
N/A
N/A
EPS
0.97
N/A
Revenue
$1,578,000,000.00
$254,136,000.00
Revenue This Year
N/A
$97.80
Revenue Next Year
N/A
$35.87
P/E Ratio
$15.00
N/A
Revenue Growth
N/A
254.30
52 Week Low
$14.05
$80.51
52 Week High
$24.10
$138.70

Technical Indicators

Market Signals
Indicator
FSK
BLLN
Relative Strength Index (RSI) 40.12 N/A
Support Level $14.12 N/A
Resistance Level $14.81 N/A
Average True Range (ATR) 0.28 0.00
MACD -0.01 0.00
Stochastic Oscillator 35.57 0.00

Price Performance

Historical Comparison
FSK
BLLN

About FSK FS KKR Capital Corp.

FS KKR Capital Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The company's investment objectives are to generate current income and, to a lesser extent, long-term capital appreciation. The company's portfolio is comprised of investments in senior secured loans and second lien secured loans of private middle market U.S. companies and, to a lesser extent, subordinated loans and certain asset-based financing loans of private U.S. companies.

About BLLN BillionToOne Inc.

BillionToOne Inc is a precision diagnostics company revolutionizing molecular testing with its patented Quantitative Counting Templates (QCT) platform. This technology enables ultrasensitive, single-molecule DNA quantification, making genetic testing more accurate, affordable, and accessible. The company serves prenatal screening and oncology markets with non-invasive tests that detect fetal genetic risks and monitor cancer therapy response.

Share on Social Networks: